Sanofi and GlaxoSmithKline would likely set roughly the same price for its coronavirus vaccine in Europe and the United States, according to comments over the weekend by a Sanofi executive, but unlike American taxpayers, Europeans did not fund the development of the vaccine. As elections near, the president is keen on showing voters that he can get the same deals on drugs as other developed countries. Olivier Bogillot, president of Sanofi France, told France Inter radio over the weekend...